Pharmicell Co., Ltd. (KRX:005690)
7,820.00
-630.00 (-7.46%)
Nov 20, 2026, 3:30 PM KST
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 469.23 billion as of November 20, 2026. It is the 16,257th most valuable company in the world and the 431st biggest in South Korea. Its market cap has decreased by 54.80% in one year.
Market Cap
469.23B
Enterprise Value
n/a
Revenue
23.94B
Global Rank
Country Rank
#431 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 469.23B, an increase of 1,045.59%. That is a compound annual growth rate of 8.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 469.23B | -46.18% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 685.44B |
| Proteina | 609.14B |
| Komipharm International | 605.23B |
| Hyundai Bioscience | 593.50B |
| Onconic Therapeutics | 468.61B |
| AbClon | 460.89B |
| Medy-Tox | 459.83B |
| GC Corp. | 433.96B |